DexCom
DXCM
#894
Rank
C$35.53 B
Marketcap
C$90.63
Share price
0.37%
Change (1 day)
-17.58%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2025 (TTM): C$1.37 Billion

According to DexCom's latest financial reports the company's current earnings are C$4.51 Billion. In 2024 the company made an earning of C$1.00 Billion a decrease over its 2023 earnings that were of C$1.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$1.37 B36.05%
2024 C$1.00 B-0.37%
2023 C$1.01 B78.13%
2022 C$0.56 B47.34%
2021 C$0.38 B-10.11%
2020 C$0.42 B88.27%
2019 C$0.22 B-258.48%
2018 -C$0.15 Billion189.94%
2017 -C$49.55 Million-44.24%
2016 -C$88.84 Million12.43%
2015 -C$79.02 Million165.58%
2014 -C$29.76 Million-25.61%
2013 -C$40 Million-48.11%
2012 -C$77.08 Million24.5%
2011 -C$61.91 Million
2008 -C$73.11 Million13.18%
2007 -C$64.6 Million-5.36%
2006 -C$68.25 Million52.08%
2005 -C$44.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Edwards Lifesciences
EW
C$2.36 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$2.60 B 92.84%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical
WST
C$0.83 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$0.29 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$8.85 B 554.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Abbott Laboratories
ABT
C$11.26 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.82 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-C$1.58 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA